436 related articles for article (PubMed ID: 34496841)
1. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
[TBL] [Abstract][Full Text] [Related]
2. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
3. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
4. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
5. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
6. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
Chen W; Chen X; Li S; Ren B
J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
[TBL] [Abstract][Full Text] [Related]
7. Coiled-coil domain-containing protein 58 (CCDC58) is a novel prognostic biomarker correlated with mitochondrial functions in hepatocellular carcinoma.
Chen L; Zhang J; Yang Y; Shu J; Zheng J; Zhan X; Guo M
Am J Transl Res; 2023; 15(4):2568-2584. PubMed ID: 37193151
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
9. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
10. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
11. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
12. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
[TBL] [Abstract][Full Text] [Related]
13. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma.
Yang Y; Li J; Tang M; Nie B; Huang W
Cancer Manag Res; 2022; 14():1627-1639. PubMed ID: 35535267
[TBL] [Abstract][Full Text] [Related]
14. Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma.
Chen GL; Ye T; Chen HL; Zhao ZY; Tang WQ; Wang LS; Xia JL
Oncogenesis; 2017 Sep; 6(9):e382. PubMed ID: 28945217
[TBL] [Abstract][Full Text] [Related]
15. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
16.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
17. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
Ma C; Kang W; Yu L; Yang Z; Ding T
Front Oncol; 2020; 10():590006. PubMed ID: 33363020
[TBL] [Abstract][Full Text] [Related]
18. LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8
Xiao S; Lu L; Lin Z; Ye X; Su S; Zhang C; You Y; Li W; Huang X; Wu W; Zhou Y
J Hepatocell Carcinoma; 2024; 11():1031-1048. PubMed ID: 38859944
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
20. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]